SINT Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
SINTX Technologies Inc (SINT) is not a strong buy for a beginner, long-term investor at this moment. While the company has potential due to its innovative biomaterials and a Buy rating from analysts, the financial performance is weak, and there are no significant positive catalysts or trading signals to justify an immediate investment. Holding off for now is advisable.
The MACD is positive but contracting, RSI is neutral at 49.424, and moving averages are converging, indicating no clear trend. The stock is trading near its pivot level of 2.699, with resistance at 2.924 and support at 2.474.
Analyst coverage initiated with a Buy rating and a $10 price target, citing innovative silicon nitride-based biomaterials with strong commercial potential.
Weak financial performance in Q4 2025, with revenue down 46.49% YoY, EPS down 54.76% YoY, and gross margin declining by 9.44%. No recent news or significant trading trends from insiders or hedge funds.
In Q4 2025, revenue dropped to $290,000 (-46.49% YoY), net income improved to -$2,215,000 (+30.68% YoY), EPS declined to -0.57 (-54.76% YoY), and gross margin fell to 64.83% (-9.44% YoY).
H.C. Wainwright initiated coverage with a Buy rating and a $10 price target, highlighting the company's potential to disrupt traditional orthopedic implant materials.
